Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasms × Melatonin × Clear all

Phase

Phase 2/3 3 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Parasomnias 2 Weight Loss 1 Uveal Melanoma 1 Tuberous Sclerosis 1 Squamous Cell Carcinoma of Head and Neck 1 Smith-Magenis Syndrome 1 Sleep Wake Disorders 1 Neoplasms 1 Lung Neoplasms 1 Gastrointestinal Neoplasms 1 Cachexia 1 Breast Cancer - Female 1 Barrett Esophagus 1 Autism Spectrum Disorder 1 Anorexia 1 Angelman Syndrome 1

Interventions

Paclitaxel 19 Dexamethasone 16 Bevacizumab 16 Oxaliplatin 14 Docetaxel 14 Capecitabine 12 Gemcitabine 11 Cyclophosphamide 11 Sorafenib 10 Leucovorin 10 Fluorouracil 10 Carboplatin 10 Epoetin Alfa 9 pembrolizumab 8 Pemetrexed 8 Fentanyl 8 venetoclax 7 atezolizumab 7 Rivaroxaban 6 Prednisone 6 Ondansetron 6 Morphine 6 Irinotecan 6 Drug Therapy 6 Doxorubicin 6 Denosumab 6 Cisplatin 6 Tranexamic Acid 5 Sodium Chloride 5 Panitumumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02454855 2022-06-13

MEQAPAG

Centre Jean Perrin

Phase 3 Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡